GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Takeda Pharmaceutical Co Ltd ADR TAK · USD

Health Care · US listing · 🇺🇸 United States

Compare

21.09

+0.33%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Takeda Pharmaceutical Co Ltd ADR annual report

Filed with the US Securities and Exchange Commission

20-F

The latest annual report covers the year to 31 Mar 2026, filed on 17 Jun 2026.

Read the 20-F on SEC.gov ↗

Five-year highlights

In USD.

FY2026FY2025FY2024FY2023FY2022
Revenue$29.99bn$28.76bn$26.77bn$25.29bn$22.41bn
Operating income$3.60bn$2.15bn$3.14bn$3.08bn$2.89bn
Net income$1.28bn$677.6m$904.5m$1.99bn$1.44bn
Free cash flow$3.94bn$4.25bn$1.48bn$2.16bn$5.88bn
Total assets$97.44bn$89.46bn$94.86bn$87.63bn$82.74bn
Shareholders' equity$49.02bn$43.54bn$45.66bn$39.89bn$35.68bn

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.